Stem Cell Stocks Get Boost on Democrat Win

Stem cell stocks are higher today following a clear win for the Democrats in the House and a possible win in the Senate. The Dems could push for more funding and could even attempt to bring back a bill for controversial embryonic stem cell research , a bill Bush vetoed this summer.

Stem Cell Stocks: Aastrom Biosciences Inc (Nasdaq: ASTM), StemCells Inc (Nasdaq: STEM), VIACELL, INC. (Nasdaq: VIAC), Geron Corporation's (Nasdaq: GERN), Cytori Therapeutics, Inc. (Nasdaq: CYTX), Advanced Cell Technology Inc. (OTCBB: ACTC)